ICMR chief justifies emergency approval citing safety & immunogenicity

Even as the Covid-19 vaccine is likely to arrive in Delhi by early next week, restricted emergency use of vaccines is considered based on safety and immunogenicity data, said Indian Council of Medical Research (ICMR) chief Balram Bhargava. Continue Reading

Unscientific therapies can lead to virus mutations: ICMR chief

Non-judicious use of therapies, that have not been scientifically established for treating Covid-19, put immune pressure on the virus which can lead to mutations, said Indian Council of Medical Research (ICMR) chief Balram Bhargava amid concerns over the United Kingdom variant of the coronavirus. Continue Reading